object
felin
leukaemia
viru
felv
gamma
retroviru
caus
diseas
felin
haematopoiet
system
invari
fatal
rapid
accur
test
pointofne
pon
support
prevent
viru
spread
manag
clinic
diseas
studi
evalu
perform
insul
isotherm
pcr
iipcr
detect
provir
dna
revers
transcript
rt
iipcr
detect
viral
rna
provir
dna
felv
detect
pon
method
mycoplasma
haemof
felin
coronaviru
felin
herpesviru
felin
caliciviru
felin
immunodefici
viru
use
test
analyt
specif
vitro
transcrib
rna
artifici
plasmid
felv
strain
american
type
cultur
collect
clinic
felv
isol
use
analyt
sensit
assay
retrospect
studi
includ
clinic
plasma
serum
sampl
test
viru
isol
realtim
pcr
elisa
prospect
studi
includ
clinic
plasma
serum
sampl
implement
evalu
clinic
perform
iipcrbas
method
felv
detect
result
ninetyf
percent
assay
limit
detect
calcul
rna
five
dna
copi
rtiipcr
six
dna
copi
iipcr
reaction
analyt
sensit
compar
refer
realtim
pcr
qpcr
detect
five
nontarget
felin
pathogen
clinic
perform
rtiipcr
iipcr
agreement
kappa
agreement
respect
qpcr
n
agreement
automat
nucleic
extractionrtiipcr
system
viru
isol
detect
felv
plasma
serum
retrospect
n
prospect
n
studi
respect
conclus
relev
result
suggest
rtiipcr
iipcr
assay
serv
reliabl
tool
pon
felv
detect
felin
leukaemia
viru
felv
gamma
retroviru
caus
malign
prolif
degen
disord
felin
haematopoiet
system
common
outcom
felv
infect
regress
infect
wherebi
cat
clear
infecti
viru
blood
retain
provir
dna
infect
cell
progeni
altern
progress
infect
felv
replic
goe
uncheck
infecti
viru
viral
rna
recov
persist
bloodstream
progress
infect
cat
provid
major
reservoir
infect
die
within
year
haematopoiet
disord
preval
felv
declin
worldwid
owe
widespread
use
effect
vaccin
well
test
remov
polici
accur
rapid
identif
felvinfect
cat
pointofne
pon
support
strategi
toward
viru
erad
mani
diagnost
test
alreadi
avail
includ
immunoassay
detect
circul
felv
antigen
viru
isol
vi
assay
recov
circul
infecti
viru
molecular
assay
detect
either
viral
rna
revers
transcript
realtim
pcr
rtqpcr
integr
provir
dna
qpcr
immunoassay
predominantli
use
rapid
screen
test
pon
howev
given
declin
preval
felv
consequ
increas
falseposit
result
signific
posit
result
current
recommend
antigenposit
sampl
retest
use
second
method
delay
decisionmak
welfar
cost
implic
particularli
shelter
vi
gold
standard
felv
infect
diagnosi
readili
avail
privat
practition
furthermor
test
labori
long
turnaround
time
increasingli
sensit
molecular
assay
rtqpcr
qpcr
view
practic
altern
antigen
vi
test
rtqpcr
assay
detect
viral
rna
correl
well
viraemia
progress
infect
wherea
qpcr
assay
detect
provir
dna
integr
genom
infect
cell
progress
regress
infect
cat
harbour
provir
dna
quantit
assay
assist
distinguish
popul
molecular
assay
recommend
detect
felvexpos
cat
investig
obscur
clinic
case
screen
potenti
blooddonor
cat
howev
rtqpcr
qpcr
assay
current
restrict
commerci
diagnost
laboratori
owe
requir
sophist
instrument
skill
technician
rapid
afford
userfriendli
platform
need
pon
detect
felv
viral
rna
provir
dna
convect
pcr
insul
isotherm
pcr
iipcr
repres
new
gener
pcr
technolog
methodolog
simpl
costeffect
rapid
potenti
fielddeploy
one
iipcr
system
portabl
pockit
nucleic
acid
analyz
genereach
usa
commerci
avail
devic
equip
simpl
heat
sourc
establish
natur
thermal
convect
capillari
tube
hydrolysi
probe
eg
taqman
probe
gener
optic
signal
convert
sn
ratio
signal
signal
automat
report
positiveneg
result
digit
screen
modul
accumul
evid
avail
support
assert
clinic
perform
pockit
system
compar
variou
laboratori
qpcr
nest
pcr
assay
number
veterinarysignific
pathogen
includ
felin
immunodefici
viru
fiv
canin
parvoviru
canin
distemp
viru
equin
influenza
viru
subtyp
classic
swine
fever
viru
blue
tongu
viru
take
advantag
pockit
system
commerci
rtiipcr
detect
viral
rna
provir
dna
pockit
felv
reagent
set
genereach
usa
iipcr
detect
provir
dna
pockit
felv
reagent
set
rt
genereach
usa
develop
help
pon
identif
felvexpos
cat
fielddeploy
manual
automat
nucleic
acid
extract
method
avail
work
pockit
system
pon
applic
petnad
nucleic
acid
coprep
kit
taco
mini
nucleic
acid
automat
extract
system
taco
mini
respect
genereach
usa
studi
evalu
analyt
sensit
specif
felv
rtiipcr
iipcr
reagent
set
diagnost
perform
verifi
comparison
routin
method
provir
qpcr
assay
vi
use
two
diagnost
laboratori
one
usa
one
uk
respect
collect
clinic
sampl
perform
autom
nucleic
acid
extract
system
combin
rtiipcr
felv
nucleic
acid
detect
also
evalu
residu
plasma
serum
clinic
sampl
submit
veterinari
diagnost
servic
univers
glasgow
vdsug
uk
veterinari
practition
felv
vi
test
includ
retrospect
studi
sampl
viposit
vineg
test
previous
use
vi
felv
provir
qpcr
inhous
antigen
elisa
describ
prospect
studi
wholeblood
edta
heparinis
plasma
serum
sampl
submit
vdsug
routin
diagnost
test
studi
period
elig
inclus
provid
suffici
residu
volum
avail
total
sampl
collect
period
month
viru
isol
cell
clone
felin
fibroblast
moloney
murin
sarcoma
proviru
introduc
routin
use
felv
vi
vdsug
subconflu
layer
cell
plate
heparinis
plasma
serum
absorb
h
replac
fresh
tissu
cultur
medium
dulbecco
modifi
eagl
medium
contain
glutamin
sodium
pyruv
penicillinstreptomycin
life
technolog
cell
examin
characterist
cytopath
effect
daili
day
neg
cell
subcultur
day
posit
whole
infecti
viru
neg
tissu
cultur
medium
control
includ
plate
plasmid
contain
fragment
long
termin
repeat
ltr
region
felv
use
evalu
analyt
sensit
assay
gener
rna
templat
vitro
transcript
ivt
use
maxiscript
kit
ambion
ivt
rna
residu
dna
remov
use
ambion
turbo
dnafre
kit
appli
biosystem
concentr
dna
rna
measur
use
spectrophotomet
nanodrop
thermo
scientif
singleus
aliquot
store
serial
dilut
made
yeast
trna
test
utvmc
provir
qpcr
vdsug
dna
extract
use
qiaamp
dna
blood
mini
kit
qiagen
accord
manufactur
site
extract
nucleic
acid
buffi
coat
obtain
edta
blood
elut
perform
nucleasefre
water
utvmc
ae
buffer
vdsug
per
proprietari
nucleic
acid
extract
taco
mini
use
taco
dnarna
extract
kit
genereach
usa
heparinis
plasma
serum
subject
extract
step
describ
manufactur
manual
total
nucleic
acid
elut
elut
buffer
either
test
immedi
store
provir
qpcr
describ
tandon
et
al
tabl
use
routin
detect
felv
provir
dna
utvmc
vdsug
reaction
run
realtim
thermal
cycler
utvmc
smart
cycler
cepheid
programm
includ
initi
denatur
step
min
follow
cycl
vdsug
reaction
run
differ
realtim
thermal
cycler
abi
appli
biosystem
programm
ran
initi
min
min
follow
cycl
min
felv
rtiipcr
iipcr
reagent
set
pockit
felv
reagent
set
pockit
felv
reagent
set
rt
respect
design
target
wellconserv
felv
ltr
region
exclud
known
felvlik
endogen
retrovir
sequenc
briefli
lyophilis
premix
rehydr
premix
buffer
b
nucleic
acid
sampl
ad
subsequ
final
mixtur
transfer
rtube
spun
briefli
minicentrifug
cube
genereach
usa
place
pockit
devic
turnaround
time
less
h
default
programm
pockit
result
shown
posit
neg
run
posit
manufactur
suppli
neg
pcrgrade
water
templat
control
use
antigen
elisa
doubl
antibodi
sandwich
elisa
microelisa
plate
coat
two
custommad
antibodi
recognis
distinct
epitop
biotinyl
polyclon
antibodi
aviva
system
biolog
ad
plate
follow
clinic
sampl
mix
incub
min
follow
incub
min
phosphataselabel
streptavidin
conjug
sigmaaldrich
final
min
incub
phosphatas
substrat
sigmaaldrich
preced
quench
phosphatas
activ
sodium
hydroxid
sigmaaldrich
absorb
measur
use
spectrophotomet
multiskan
micropl
reader
thermo
scientif
high
low
posit
sampl
well
neg
sampl
includ
control
sampl
consid
posit
absorb
equal
exceed
neg
control
valu
statist
probit
analysi
nonlinear
regress
model
perform
determin
limit
detect
lod
lowest
target
concentr
could
detect
confid
interv
ci
use
commerci
softwar
spss
ibm
conting
tabl
analys
kappa
statist
use
spss
determin
interrat
agreement
analyt
specif
felv
rtiipcr
iipcr
reagent
set
assess
test
signific
felin
pathogen
haemof
fcov
fhv
fcv
fiv
neither
reagent
set
react
member
test
panel
felv
iipcr
design
detect
felv
provir
dna
exclus
analyt
sensit
determin
use
serial
dilut
plasmid
dna
contain
target
region
posit
signal
obtain
copi
reaction
respect
tabl
lod
six
copi
per
reaction
sensit
reagent
set
also
compar
refer
qpcr
assay
also
target
ltr
region
tenfold
serial
dilut
nucleic
acid
prepar
cell
infect
atcc
strain
felva
clinic
isol
test
detect
limit
provir
qpcr
found
dilut
strain
cycl
threshold
ct
type
isol
ct
similarli
iipcr
reach
detect
limit
dilut
strain
type
isol
tabl
respect
indic
felv
iipcr
sensit
qpcr
detect
provir
dna
felv
rtiipcr
could
detect
viral
rna
provir
dna
analyt
sensit
felv
rtiipcr
rna
dna
evalu
dilut
seri
ivt
rna
plasmid
contain
target
sequenc
respect
posit
signal
obtain
reaction
contain
copi
ivt
rna
respect
tabl
addit
plasmid
dna
reaction
contain
copi
respect
posit
accordingli
lod
copi
rna
five
copi
dna
per
reaction
addit
sensit
reagent
set
compar
provir
qpcr
assay
test
replic
dilut
nucleic
acid
cell
infect
either
felv
atcc
strain
felva
isol
detect
endpoint
rtiipcr
qpcr
found
dilut
atcc
strain
respect
felva
isol
end
point
assay
dilut
tabl
result
indic
felv
rtiipcr
compar
qpcr
detect
felv
nucleic
acid
like
refer
qpcr
felv
iipcr
could
detect
provir
dna
clinic
perform
reagent
set
compar
side
side
provir
qpcr
routin
use
utvmc
laboratori
use
clinic
sampl
collect
nucleic
acid
extract
buffi
coat
edta
blood
use
qiaamp
dna
mini
kit
analys
refer
qpcr
iipcr
method
parallel
sampl
test
test
posit
neg
qpcr
vdsug
clinic
perform
combin
taco
mini
felv
rtiipcr
taco
mini
rtiipcr
system
verifi
vi
perform
routin
diagnosi
felv
viraemia
vdsug
felv
provir
qpcr
antigen
elisa
test
also
employ
frequent
determin
clinic
stage
felv
infect
initi
retrospect
studi
perform
use
felin
heparinis
plasma
serum
sampl
previous
test
vi
elisa
andor
qiaamp
dna
miniqpcr
system
among
previous
test
posit
neg
vi
taco
minirtiipcr
system
react
posit
viposit
sampl
vineg
sampl
tabl
three
four
vineg
sampl
posit
taco
minirtiipcr
qiaamp
dna
miniqpcr
system
ct
respect
three
antigen
posit
elisa
data
shown
one
vineg
sampl
test
posit
taco
mini
rtiipcr
test
qiaamp
dna
miniqpcr
system
ct
neg
antigen
elisa
sampl
test
neg
taco
minirtiipcr
posit
vi
also
antigen
posit
qpcr
carri
sampl
insuffici
sampl
remain
experiment
analysi
agreement
taco
mini
rtiipcr
system
vi
ci
compar
vi
method
sensit
ci
specif
ci
prospect
studi
sampl
collect
uk
cat
within
month
subject
taco
minirtiipcr
system
vi
qiaamp
dna
miniqpcr
system
parallel
total
six
sampl
posit
neg
vi
tabl
indic
preval
felv
infect
studi
region
like
rel
low
six
viposit
two
vineg
sampl
posit
taco
mini
rtiipcr
system
one
vineg
sampl
gave
posit
result
pcrbase
method
ct
elisa
vdsug
number
tabl
second
vineg
sampl
test
neg
qpcr
elisa
subsequ
test
neg
pockit
repeat
test
number
tabl
compar
vi
taco
minirtiipcr
system
sensit
ci
specif
tabl
evalu
analyt
sensit
felin
leukaemia
viru
felv
insul
isotherm
pcr
iipcr
revers
transcript
rt
iipcr
reagent
set
use
nucleic
acid
prepar
felvinfect
cell
ci
two
method
agreement
ci
felv
iipcr
rtiipcr
perform
similarli
refer
qpcr
vi
test
clinic
sampl
discrep
three
retrospect
one
prospect
vineg
sampl
test
vdsug
posit
taco
minirtiipcr
qiaamp
dna
miniqpcr
system
ct
respect
antigen
posit
elisa
vdsug
laboratori
diagnost
laboratori
low
qpcr
ct
valu
consist
viraemia
addit
vdsug
laboratori
provirusposit
sampl
antigenaem
high
probabl
viraemia
data
shown
four
sampl
proviru
antigen
posit
like
vi
result
fals
neg
although
sensit
vi
still
depend
success
recoveri
live
viru
blood
sampl
may
fail
owe
nonviabl
viru
undetect
viral
load
result
fourth
retrospect
sampl
test
neg
vi
antigen
elisa
posit
rtiipcr
qpcr
ct
suggest
felv
virion
activ
produc
provir
dna
regress
infect
vdsug
one
retrospect
viposit
sampl
unexpectedli
neg
taco
minirtiipcr
system
one
possibl
may
poor
qualiti
degener
nucleic
acid
rna
particularli
fragil
extract
altern
presenc
sampl
inhibitor
may
interf
reaction
viral
load
rel
low
may
lead
posit
result
repeat
test
one
retrospect
sampl
discrep
result
iipcr
neg
provir
qpcr
posit
ct
utvmc
tabl
four
prospect
sampl
neg
taco
mini
rtiipcr
system
vi
posit
use
qiaamp
dna
miniqpcr
system
ct
ct
ct
ct
number
tabl
vdsug
interest
find
may
reflect
test
divers
blood
fraction
studi
vdsug
qpcr
screen
cell
within
buffi
coat
provir
dna
wherea
vi
rtiipcr
assay
test
plasma
serum
whole
infecti
virion
viral
rna
detect
provir
dna
high
ct
level
failur
detect
viral
rna
infecti
viru
plasma
serum
suggest
four
cat
regress
infect
might
suggest
use
rtiipcr
test
differ
blood
fraction
may
assist
distinguish
progress
regress
infect
cat
test
serum
viral
rna
test
buffi
coat
viral
rna
provir
dna
posit
result
serum
would
suggest
progress
infect
howev
retrospect
studi
one
cat
suspect
regress
infect
test
posit
use
rtiipcr
plasma
serum
may
absolut
reliabl
highli
recommend
felv
infect
statu
determin
introduct
cat
group
hous
administr
felv
vaccin
blood
donat
help
mitig
spread
felv
onsit
sensit
test
prior
blood
transfus
could
help
reduc
unintent
felv
transmiss
time
isol
remov
felvinfect
cat
multicat
household
shelter
board
kennel
environ
also
import
felv
infect
control
increasingli
recognis
may
import
identifi
felvexpos
cat
irrespect
infect
statu
region
felv
preval
low
identifi
felvexpos
cat
may
import
step
toward
felv
erad
although
regress
infect
cat
appear
low
risk
develop
felvrel
diseas
previous
believ
pose
signific
infect
risk
healthi
cat
recent
studi
conclud
regress
infect
reactiv
resum
viru
replic
shed
diseas
although
rapid
antigen
immunoassay
serv
initi
screen
test
patientsid
identifi
cat
regress
infect
portion
cat
regress
infect
addit
felv
rna
could
detect
circul
tissu
regress
infect
cat
even
absenc
detect
provir
dna
gener
pcr
method
sensit
specif
antigen
immunoassay
therefor
fielddeploy
felv
rtiipcr
pockit
system
excel
sensit
rna
dna
templat
recommend
method
identifi
felvexpos
cat
patientsid
prefer
sampl
buffi
coat
test
plasma
serum
rtiipcr
may
exclud
low
number
regress
infect
cat
wherea
clinic
perform
assay
excel
agreement
refer
method
buffi
coat
test
tabl
cost
pockit
micro
plu
devic
reagent
us
us
respect
shall
allow
costeffect
onsit
screen
felvexpos
anim
even
shelter
set
facilit
erad
felv
infect
commun
long
run
integr
felv
provir
dna
elimin
host
immun
system
therefor
progress
regress
infect
cat
popul
test
posit
provir
dna
use
iipcr
reagent
set
unlik
quantit
provir
qpcr
assay
iipcr
use
differenti
cat
popul
howev
provir
iipcr
could
potenti
work
rapid
immunoassay
suitabl
patientsid
tool
aid
felv
infect
confirm
diagnosi
given
studi
demonstr
analyt
clinic
perform
compar
provir
qpcr
combin
provir
pcr
method
antigen
immunoassay
shown
achiev
diagnost
sensit
instanc
provir
dna
iipcrposit
result
suggest
progress
infect
iipcrposit
result
suggest
regress
infect
potenti
futur
viral
reactiv
addit
screen
rapid
antigen
immunoassay
alon
carri
risk
falseposit
result
owe
crossreact
exacerb
popul
low
felv
preval
posit
antigen
result
standalon
rapid
antigen
immunoassay
could
follow
antigen
immunoassay
provir
iipcr
pon
suggest
provid
automat
interpret
signal
fluoresc
probe
pockit
method
suffici
userfriendli
run
anim
shelter
personnel
clinic
technic
staff
basic
train
requir
open
reaction
tube
stage
significantli
reduc
risk
carryov
contamin
pcr
amplicon
pockit
throughput
handheld
version
pockit
micro
plu
throughput
genereach
usa
small
lightweight
robust
could
oper
recharg
batteri
car
batteri
lowresourc
set
reagent
set
offer
lyophilis
format
allow
easi
ship
storag
moreov
fielddeploy
automat
nucleic
acid
extract
devic
help
simplifi
nucleic
acid
prepar
step
taco
miniiipcr
system
allow
user
obtain
result
clinic
sampl
h
resourcelimit
set
manual
nucleic
acid
extract
method
petnad
nucleic
acid
coprep
kit
also
avail
may
less
suitabl
pon
set
given
requir
appropri
technic
compet
prolong
handson
time
perform
similar
vi
provir
qpcr
rtiipcr
detect
viral
rna
dna
provir
iipcrpockit
system
could
help
rule
prior
exposur
felv
pon
would
facilit
time
identif
care
placement
felvinfect
anim
facil
veterinari
clinic
shelter
custom
inspect
port
entri
